Leena Das-Young

Leena Das-Young is currently an advisor at Embleema. Leena has previously worked as the general manager and chief lunar officer at Guardant Health, vice president at Pfizer, and head of late phase strategy and development group at Oncology. Das-Young has been working in the medical field for many years and has been a part of many groundbreaking projects. Some of their most notable accomplishments include being part of the team that got Mylotarg back on the market and helping to develop Xtandi for non-metastatic castration-resistant prostate cancer. Das-Young is a highly skilled and experienced medical professional who has dedicated their career to helping others.

Leena Das-Young completed a Doctor of Pharmacy (PharmD) at Purdue University in the field of Clinical Pharmacy. Prior to that, they completed a BS Pharmacy at Purdue University.